Abstract
The University of Central Florida invention is an anti-malarial compound, a type II kinase inhibitor, with a novel scaffold. The compound exhibits therapeutic and prophylactic properties in animal models and has a favorable pharmacological profile.
Benefit
Compound inhibits asexual stage maturation of parasites earlyExhibits fast killing rate and metabolic stabilityMarket Application
Anti-malarial drugs
Brochure
